ART.1 delivers automated daily dose evaluation and decision support for replanning in radiotherapy treatments—without workflow disruption or hardware upgrades VIENNA, April 30, 2025 /PRNewswire-PRWeb/ -- SeeTreat will debut its first clinical product, ART.1, at Booth 820 during ESTRO 2025...
↧